<DOC>
	<DOCNO>NCT03014206</DOCNO>
	<brief_summary>This study aim understand follow item post-marketing actual clinical setting evaluate safety 13vPnC administer single dose elderly ( adult age 65 year old ) . 1 . To confirm use actual clinical setting 2 . To confirm occurrence adverse event</brief_summary>
	<brief_title>Prevenar13 Drug Use Investigation - Adults Aged 65 Years Older-</brief_title>
	<detailed_description>This study multicenter open-label cohort conduct patient vaccinated Product ; , case report form record base data present medical record obtain day-to-day clinical treatment diagnosis . `` Pneumococcal vaccine health study diary '' implement collect accurate safety data ; , vaccine recipient ask directly cooperate .</detailed_description>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>1 . Geriatric patient vaccinated product ( adult young 65 year ) 2 . Consent vaccine recipient [ Vaccine recipient ( his/her legally acceptable representative ) must sign date consent form warrant relevant information concern Study appropriately communicate recipient ] .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>